Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
Arbutus Biopharma Corp reports 2022 executive compensation
By ExecPay News
Published: April 12, 2023
Arbutus Biopharma Corp reported fiscal year 2022 executive compensation information on April 12, 2023.
In 2022, three executives at Arbutus Biopharma Corp received on average a compensation package of $1.7M, a 17% decrease compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
William H. Collier, Chief Executive Officer, received $2.6M in total, which decreased by 18% compared to 2021. 65% of Collier's compensation, or $1.7M, was in option awards. Collier also received $316K in non-equity incentive plan, $607K in salary, as well as $11K in other compensation.
Michael J. McElhaugh, Chief Operating Officer, received a compensation package of $1.3M. 54% of the compensation package, or $709K, was in option awards.
Michael Sofia, Chief Scientific Officer, earned $1.2M in 2022, a 22% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2023.